Cardiology

Canine Study 1:

Title:	EPIC Study
Contact Person:	If you, your staff or clients would like more information or to set up appointments for screening please contact Kathy Glaze Phone: 979-845-2351 Email: kglaze@cvm.tamu.edu (put Heart Studies in the subject line)
Species:	Canines
Study Summary:	EPIC Study Summary This study will evaluate if pimobendan (Vetmedin®) can prolong the asymptomatic stage of chronic leaky mitral valve disease (i.e. delay the onset of heart failure/pulmonary edema). It is a placebo controlled study that is fully funded (no cost to the owner). The study requires screening to determine if all entry criteria are met and then follow-up appointments (approximately every 4 months) at TAMU.
Eligibility for EPIC free screening including a physical exam and echocardiogram at TAMU	Relatively healthy dogs greater or equal to 6 year of age Weight between 9 and 33.1 lbs (must weigh at least 9 lbs) Heart murmur from leaky mitral valve greater than or equal to 3/6 Willing to come to Texas A & M approximately every 4 months for 4-5 years Fulfill the rest of the screening criteria which can be determined during a free screening visit to Texas A & M. Not taking enalapril, benazepril, furosemide, pimobendan or a beta-blocker such as atenolol or carvedilol Client willing to consider taking part in a placebo controlled clinical study